The Turkish Medicines and Medical Devices Agency has issued a series of regulatory updates affecting pharmaceuticals, medical devices, and clinical research operations. These announcements introduce new guidelines for tissue and cell product imports, advanced therapy medicinal products, ethics committee procedures, and pharmaceutical pricing mechanisms. Stakeholders in Turkey's healthcare sector must navigate these evolving compliance requirements while the European Commission simultaneously seeks input on